Price Eric W, Zeglis Brian M, Cawthray Jacqueline F, Lewis Jason S, Adam Michael J, Orvig Chris
Medicinal Inorganic Chemistry Group, Department of Chemistry, University of British Columbia , 2036 Main Mall, Vancouver, British Columbia V6T 1Z1, Canada.
Inorg Chem. 2014 Oct 6;53(19):10412-31. doi: 10.1021/ic501466z. Epub 2014 Sep 5.
The acyclic ligands H4C3octapa and p-SCN-Bn-H4C3octapa were synthesized for the first time, using nosyl protection chemistry. These new ligands were compared to the previously studied ligands H4octapa and p-SCN-Bn-H4octapa to determine the extent to which the addition of a single carbon atom to the backbone of the ligand would affect metal coordination, complex stability, and, ultimately, utility for in vivo radiopharmaceutical applications. Although only a single carbon atom was added to H4C3octapa and the metal donor atoms and denticity were not changed, the solution chemistry and radiochemistry properties were drastically altered, highlighting the importance of careful ligand design and radiometal-ligand matching. It was found that In(C3octapa) and Lu(C3octapa) were substantially different from the analogous H4octapa complexes, exhibiting fluxional isomerization and a higher number of isomers, as observed by (1)H NMR, VT-NMR, and 2D COSY/HSQC-NMR experiments. Past evaluation of the DFT structures of In(octapa) and Lu(octapa) revealed very symmetric complexes; in contrast, the In(C3octapa) and Lu(C3octapa) complexes were much less symmetric, suggesting lower symmetry and less rigidity than that of the analogous H4octapa complexes. Potentiometric titrations revealed the formation constants (log K(ML), pM) were 2 units lower for the In(3+) and Lu(3+) complexes of H4C3octapa when compared to that of the more favorable H4octapa ligand (2 orders of magnitude less thermodynamically stable). The bifunctional ligands p-SCN-Bn-H4C3octapa and p-SCN-Bn-H4octapa were conjugated to the antibody trastuzumab and radiolabeled with (111)In and (177)Lu. Over a 5 day stability challenge experiment in blood serum, (111)In-octapa- and (111)In-C3octapa-trastuzumab immunoconjugates were determined to be ~91 and ~24% stable, respectively, and (177)Lu-octapa- and (177)Lu-C3octapa-trastuzumab, ~89% and ~4% stable, respectively. This work suggests that 5-membered chelate rings are superior to 6-membered chelate rings for large metal ions like In(3+) and Lu(3+), which is a crucial consideration for the design of bifunctional chelates for bioconjugation to targeting vectors for in vivo work.
首次使用 nosyl 保护化学合成了无环配体 H4C3octapa 和 p-SCN-Bn-H4C3octapa。将这些新配体与先前研究的配体 H4octapa 和 p-SCN-Bn-H4octapa 进行比较,以确定在配体主链上添加单个碳原子对金属配位、配合物稳定性以及最终对体内放射性药物应用效用的影响程度。尽管仅向 H4C3octapa 中添加了单个碳原子,且金属供体原子和齿数未改变,但溶液化学和放射化学性质却发生了巨大变化,突出了精心设计配体和放射性金属-配体匹配的重要性。研究发现,In(C3octapa) 和 Lu(C3octapa) 与类似的 H4octapa 配合物有很大不同,通过 (1)H NMR、VT-NMR 和 2D COSY/HSQC-NMR 实验观察到,它们表现出动态异构化且异构体数量更多。过去对 In(octapa) 和 Lu(octapa) 的 DFT 结构评估显示出非常对称的配合物;相比之下,In(C3octapa) 和 Lu(C3octapa) 配合物的对称性要低得多,这表明其对称性低于类似的 H4octapa 配合物且刚性更小。电位滴定表明,与更有利的 H4octapa 配体相比,H4C3octapa 的 In(3+) 和 Lu(3+) 配合物的形成常数(log K(ML),pM)低约 2 个单位(热力学稳定性低约 2 个数量级)。双功能配体 p-SCN-Bn-H4C3octapa 和 p-SCN-Bn-H4octapa 与抗体曲妥珠单抗偶联,并用 (111)In 和 (177)Lu 进行放射性标记。在血清中进行的为期 5 天的稳定性挑战实验中,(111)In-octapa- 和 (111)In-C3octapa-曲妥珠单抗免疫偶联物的稳定性分别测定为约 91% 和约 24%,(177)Lu-octapa- 和 (177)Lu-C3octapa-曲妥珠单抗的稳定性分别为约 89% 和约 4%。这项工作表明,对于 In(3+) 和 Lu(3+) 等大金属离子,五元螯合环比六元螯合环更具优势,这是设计用于与体内工作靶向载体进行生物偶联的双功能螯合物时的关键考虑因素。